Found 0 matching trials
Study of Methylnaltrexone (MNTX) for the Relief of Constipation
PHASE3To determine the efficacy of subcutaneous MNTX to relieve opioid-induced co...
Location
Progenics Pharmaceuticals, Inc.
Open-Label Treatment Extension of Protocol MNTX 301
PHASE3This study is an open-label extension allowing patients who have completed ...
Location
Progenics Pharmaceuticals
Study Evaluating Long-Term Safety of MOA-728 in Participants With Opioid-Induced Constipation
PHASE3This study is designed to evaluate the long-term safety and tolerability of...
Location
Pfizer Investigational Site
Opioids and Esophageal Function
PHASE4The purpose of this study is to evaluate if opioid-induced effects on the p...
Location
Department of Anaesthesiology, University Hospital Örebro
Compassionate Use Study of Methylnaltrexone
NAThis is an open label compassionate use study of subcutaneously administere...
Location
Progenics Pharmaceuticals, Inc.